[Current approach to the treatment of early forms of cervix cancer]

The effectiveness of treatment of early cancer of the uterine cervix (TIS, Tla and Tlb) is subject to evaluation of tumor stage, concomitant diseases and patient's age as well as the degree of neoplastic process and immunologic vigor. Complex treatment should be unoffensive for immunity. Immunodepressive agents should be used in conjunction with immunostimulants.